Your trusted adviser for R&D Tax Credits and R&D Grants
Myriad is proud to announce that 4 of our clients who applied for the Disruptive Technologies Innovation Fund were all approved on Monday 10th December.
Myriad is proud to announce that four of our clients who applied for the Disruptive Technologies Innovation Fund were approved on Monday, December 10th.
With a combined grant value of €14.9m, this will provide a major boost to the MedTech and Cellular Therapy communities in Galway.
The first 27 projects from Ireland’s €500m Disruptive Technologies Innovation Fund (DTIF) were announced this week and will receive a combined €75m in support.
Marc Greatrex, Director of Grants at Myriad commented the success of these applications was a testament to the strength of concepts with the passion, drive and commitment of the SMEs in Galway “We are absolutely thrilled and humbled to have 4 out of 4 applications accepted by the DTIF, we were always hopeful and glad we could help these consortia secure the funding. The technologies they're developing will have a major impact on patients and on the Irish National Strategic Outcomes in the coming years”
The projects include a scheme to help communities generate their own electricity, new treatments for sepsis, a support system for coastal flooding and advanced 3D printing of medical implants.
DTIF Call 8 is open with €40 million available. See the 3 February 2027 deadline, who can apply, funding rates and how to prepare your consortium.
From Innovation Vouchers to the RD&I Fund and Innovation Partnerships, here's how to match Enterprise Ireland's funding to where your project stands today.
The EIC's 2027 Work Programme draft: two-stage Pathfinder Open evaluation, single-beneficiary Transition grants, and a new year-one funding checkpoint.
Please contact us to discuss how working with Myriad can maximise and secure R&D funding opportunities for your business.
Contact us
info@myriadassociates.ie